{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T17:16:56Z","timestamp":1783963016334,"version":"3.55.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Despite proven efficacy and increased availability of therapeutic plasma exchange, thrombotic thrombocytopenic purpura (TTP) is associated with significant morbidity and mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Study Design and Methods:<\/jats:title>\n            <jats:p>This study utilized the Kids\u2019 Inpatient Database and National Inpatient Sample (2003 to 2016) to study predictors of in-hospital mortality in hospitalized TTP patients. Adjusted odds ratios of death with various putative risk factors were calculated using multiple regression analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among 1568 hospitalizations with TTP as primary admission diagnosis who underwent therapeutic plasma exchange, 69 deaths were identified (all-cause mortality, 0.04%; median time-to-death, 6\u2009wk). Overall, hospitalizations rates were fairly similar across the study period. The overall incidence of TTP related hospitalizations is 1.51 per 100,000 hospitalizations. A total of 69 deaths were reported with an all-cause in-hospital mortality rate of 0.04% (69\/1568). The median time-to-death was 6 weeks. The majority of deaths occurred in age 16 to 20 years (58%), females (56.5%), and African American (42.9%) as shown in Table 2. Mean age for nonsurvivors was 14 years and the mean age of 15 years for survivors (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.01). Younger age, male sex, African-American ethnicity, malignancy, sepsis, acute kidney injury, platelet transfusion was significantly associated with mortality in patients with TTP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Early and targeted therapy for high risk individuals should be used to guide management of TTP patients for improved survival outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000001725","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T22:39:31Z","timestamp":1581028771000},"page":"e340-e344","source":"Crossref","is-referenced-by-count":7,"title":["Predictors of In-Hospital Mortality in Thrombotic Thrombocytopenic Purpura in Children in the United States: A Population Analysis"],"prefix":"10.1097","volume":"42","author":[{"given":"Krishna Kishore","family":"Umapathi","sequence":"first","affiliation":[{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind","family":"Thavamani","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mammen","family":"Puliyel","sequence":"additional","affiliation":[{"name":"Pediatric Hematology, Metro Health Medical Center, Case Western Reserve University, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1056\/NEJMcp053024","article-title":"Clinical practice. Thrombotic thrombocytopenic purpura","volume":"354","author":"George","year":"2006","journal-title":"N Engl J Med"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura: 2010","volume":"116","author":"George","year":"2010","journal-title":"Blood"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/asheducation-2004.1.407","article-title":"Recent advances in thrombotic thrombocytopenic purpura","volume":"1","author":"Sadler","year":"2004","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1182\/asheducation-2014.1.444","article-title":"Thrombotic microangiopathy and indications for therapeutic plasma exchange","volume":"2014","author":"Adamski","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R5-20230918","first-page":"465","article-title":"Thrombotic thrombocytopenic purpura: report of three additional cases and a short review of the literature","volume":"62","author":"Cox","year":"1966","journal-title":"J S C Med Assoc"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients","volume":"325","author":"Bell","year":"1991","journal-title":"N Engl J Med"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Kremer Hovinga","year":"2010","journal-title":"Blood"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3324\/haematol.2011.049676","article-title":"Thrombotic Microangiopathies Reference C. Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience","volume":"97","author":"Benhamou","year":"2012","journal-title":"Haematologica"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/trf.13586","article-title":"Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012","volume":"56","author":"Goel","year":"2016","journal-title":"Transfusion"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1182\/blood-2014-10-605493","article-title":"Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality","volume":"125","author":"Goel","year":"2015","journal-title":"Blood"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12185-009-0478-z","article-title":"Thrombotic thrombocytopenic purpura: recognition and management","volume":"91","author":"Kiss","year":"2010","journal-title":"Int J Hematol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/pbc.24612","article-title":"Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features","volume":"60","author":"Reese","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"British Committee for Standards in H. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.1981.03320170043028","article-title":"Hazard of platelet transfusion in thrombotic thrombocytopenic purpura","volume":"246","author":"Harkness","year":"1981","journal-title":"JAMA"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00005792-198111000-00003","article-title":"Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature","volume":"60","author":"Ridolfi","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"1016.e1","DOI":"10.1016\/j.amjmed.2013.03.021","article-title":"Predictors of in-hospital mortality and acute myocardial infarction in thrombotic thrombocytopenic purpura","volume":"126","author":"Balasubramaniyam","year":"2013","journal-title":"Am J Med"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jca.21302","article-title":"Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research","volume":"29","author":"Sarode","year":"2014","journal-title":"J Clin Apher"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2352-3026(16)30018-7","article-title":"Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy","volume":"3","author":"Mariotte","year":"2016","journal-title":"Lancet Haematol"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1200\/JOP.2016.012096","article-title":"Microangiopathic hemolytic anemia and thrombocytopenia in patients with cancer","volume":"12","author":"Morton","year":"2016","journal-title":"J Oncol Pract"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3899\/jrheum.170811","article-title":"Characteristics and outcomes of patients with systemic lupus erythematosus\u2013associated thrombotic microangiopathy, and their acquired ADAMTS13 inhibitor profiles","volume":"45","author":"Yue","year":"2018","journal-title":"J Rheumatol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001725","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:48:25Z","timestamp":1695012505000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001725","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,31]]}}}